GLOBEALERT
Sign in
BUSINESS● LOWJul 30 · Jul 30, 2026, 10:33 AM

Regeneron Pharmaceuticals beats top-line and bottom-line estimates; updates FY26 outlook

Seeking Alpha Tech

Regeneron Pharmaceuticals exceeded both top-line and bottom-line estimates and provided an updated financial outlook for fiscal year 2026.

Read at Seeking Alpha Tech Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Business

BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS10m agoIndependent Bank declares $0.28 dividendSeeking Alpha TechBUSINESS11m agoBank First Non-GAAP EPS of $2.35, revenue of $86MSeeking Alpha Tech